We have located links that may give you full text access.
Five-year medical expenses of central cord syndrome: analysis using a national cohort.
Journal of Neurosurgical Sciences 2020 April
BACKGROUND: This study aimed to investigate the medical expenses and outcomes of central cord syndrome (CCS), comparing patients who received surgical and non-surgical management.
METHODS: Using a 14-year nationwide database in Taiwan, this study followed-up all patients of CCS at least 5 years. The incidence rates, medical expenses, permanently disabled spinal cord injury (SCI), and mortality rates were compared for patients who underwent surgery and those who were managed conservatively. All CCS patients were further stratified by the level of injury (C1-4 vs. C5-7) in the cost analysis.
RESULTS: A total of 1,753 patients with CCS were followed and the incidence of CCS was the highest among males aged between 60 and 70 years, at 42.4 per 1,000,000 person-years. The total medical expenses were higher in the surgery than the non-surgery group (46,586.9 vs. 28,472.4, P<0.001) because of rehabilitation. The surgery group had a significantly lower rate of mortality (Odds Ratio= 0.34, P<0.05) and lower rates of permanently disabled SCI (OR= 4.92, all P<0.001).
CONCLUSIONS: The highest incidence rates of CCS were observed among males aged between 60 and 70 years. The expenses were higher but the mortality rate was lower for surgically managed patients. Further investigation is required to correlate the neurological outcomes to the management of CCS.
METHODS: Using a 14-year nationwide database in Taiwan, this study followed-up all patients of CCS at least 5 years. The incidence rates, medical expenses, permanently disabled spinal cord injury (SCI), and mortality rates were compared for patients who underwent surgery and those who were managed conservatively. All CCS patients were further stratified by the level of injury (C1-4 vs. C5-7) in the cost analysis.
RESULTS: A total of 1,753 patients with CCS were followed and the incidence of CCS was the highest among males aged between 60 and 70 years, at 42.4 per 1,000,000 person-years. The total medical expenses were higher in the surgery than the non-surgery group (46,586.9 vs. 28,472.4, P<0.001) because of rehabilitation. The surgery group had a significantly lower rate of mortality (Odds Ratio= 0.34, P<0.05) and lower rates of permanently disabled SCI (OR= 4.92, all P<0.001).
CONCLUSIONS: The highest incidence rates of CCS were observed among males aged between 60 and 70 years. The expenses were higher but the mortality rate was lower for surgically managed patients. Further investigation is required to correlate the neurological outcomes to the management of CCS.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app